Comparison of the effectiveness of alectinib versus crizotinib followed by alectinib in patients with ALK-positive advanced non-small-cell lung cancer in real-world setting and in the ALEX study

Xue Yang, Yutao Liu, Gen Lin, Jinliang Wang, Yudong Wang, Yan Zhang, Qinxiang Guo, Fei Liang, Jun Zhao, Bo Jin, Xiaorong Dong